Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

JET Enhanced Thrombectomy Intervention Hong Kong Post Market Study

NCT06340763 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT06340763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06340763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
JET Enhanced Thrombectomy Intervention Hong Kong Post Market Study
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
August 7, 2024
Completion date
February 15, 2025
Enrollment
12 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial thrombosis, peripheral arteriovenous thrombosis, peripheral venous thrombosis